As of 2025-10-30, the Relative Valuation of Cresco Labs Inc (CL.CN) is (3.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.63 CAD, the upside of Cresco Labs Inc based on Relative Valuation is -286.2%.
The range of the Relative Valuation is (2.97) - (3.14) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 21.7x | 19.4x |
| Forward P/E multiples | 20.5x - 24.4x | 22.5x |
| Fair Price | (2.97) - (3.14) | (3.03) |
| Upside | -282.0% - -292.5% | -286.2% |
| Date | P/E |
| 2025-10-27 | -12.16 |
| 2025-10-24 | -11.82 |
| 2025-10-23 | -11.75 |
| 2025-10-22 | -10.92 |
| 2025-10-21 | -11.40 |
| 2025-10-20 | -11.89 |
| 2025-10-17 | -11.89 |
| 2025-10-16 | -12.85 |
| 2025-10-15 | -14.10 |
| 2025-10-14 | -12.99 |
| 2025-10-10 | -12.79 |
| 2025-10-09 | -13.68 |
| 2025-10-08 | -13.41 |
| 2025-10-07 | -13.96 |
| 2025-10-06 | -13.89 |
| 2025-10-03 | -13.34 |
| 2025-10-02 | -13.68 |
| 2025-10-01 | -13.55 |
| 2025-09-30 | -12.58 |
| 2025-09-29 | -12.99 |
| 2025-09-26 | -9.81 |
| 2025-09-25 | -10.16 |
| 2025-09-24 | -11.40 |
| 2025-09-23 | -10.71 |
| 2025-09-22 | -10.50 |
| 2025-09-19 | -10.50 |
| 2025-09-18 | -10.02 |
| 2025-09-17 | -9.33 |
| 2025-09-16 | -9.47 |
| 2025-09-15 | -9.12 |
| 2025-09-12 | -9.47 |
| 2025-09-11 | -9.95 |
| 2025-09-10 | -11.13 |
| 2025-09-09 | -11.75 |
| 2025-09-08 | -11.27 |
| 2025-09-05 | -11.40 |
| 2025-09-04 | -10.85 |
| 2025-09-03 | -10.92 |
| 2025-09-02 | -12.99 |
| 2025-08-29 | -14.31 |
| 2025-08-28 | -14.24 |
| 2025-08-27 | -13.61 |
| 2025-08-26 | -13.48 |
| 2025-08-25 | -12.79 |
| 2025-08-22 | -11.82 |
| 2025-08-21 | -11.54 |
| 2025-08-20 | -10.44 |
| 2025-08-19 | -9.74 |
| 2025-08-18 | -10.85 |
| 2025-08-15 | -9.12 |